Ann Dermatol.  2020 Apr;32(2):176-179. 10.5021/ad.2020.32.2.176.

Expression of Human Herpes Virus 6, 7, Epstein-Barr Virus and Cytomegalovirus in Patients with Diverse Adverse Cutaneous Reactions to Drug

• Ryoo YW
• Lee JB
• Kim WO
• Kim SA

• KMID: 2471350
• DOI: http://doi.org/10.5021/ad.2020.32.2.176

Abstract

No abstract available.

MeSH Terms

Cytomegalovirus*
Herpesvirus 4, Human*
Humans*

Reference

1. Abdullahi Rabiu A, Nordin Bin S, Mainul H. Adverse drug reactions: predisposing factors, modern classifications and causality assessment. Res J Pharm Tech. 2014; 7:1091–1098.

2. Ozcan D, Seçkin D, Bilezikçi B, Arslan H. The role of human herpesvirus-6, Epstein-Barr virus and cytomegalovirus infections in the etiopathogenesis of different types of cutaneous drug reactions. Int J Dermatol. 2010; 49:1250–1254. PMID: 21038542.

3. Draz N, Datta S, Webster DP, Cropley I. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to antituberculosis drugs and associated with human herpes virus-7 (HHV-7). BMJ Case Rep. 2013; 2013:bcr2013010348.

4. Warrington R, Silviu-Dan F, Wong T. Drug allergy. Allergy Asthma Clin Immunol. 2018; 14(Suppl 2):60. PMID: 30275849.

5. Shepherd GM. Hypersensitivity reactions to drugs: evaluation and management. Mt Sinai J Med. 2003; 70:113–125. PMID: 12634903.

6. Hoetzenecker W, Nägeli M, Mehra ET, Jensen AN, Saulite I, Schmid-Grendelmeier P, et al. Adverse cutaneous drug eruptions: current understanding. Semin Immunopathol. 2016; 38:75–86. PMID: 26553194.

7. De Paschale M, Clerici P. Serological diagnosis of Epstein-Barr virus infection: problems and solutions. World J Virol. 2012; 1:31–43. PMID: 24175209.

8. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol. 2007; 156:1083–1084. PMID: 17381452.